Ignite Creation Date:
2024-05-06 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 2:30 PM
Study NCT ID:
NCT05342389
Status:
UNKNOWN
Last Update Posted:
2022-04-22
First Post:
2022-04-16
Brief Title:
Camrelizumab Combined With Apatinib Versus Apatinib Alone in the Third-line Treatment of Metastatic Gastric Cancer
Sponsor:
Organization:
Sixth Affiliated Hospital Sun Yat-sen University